Costs of human papillomavirus vaccine delivery in low- and middle-income countries: A systematic review.

ABSTRACT: Vaccines to protect against human papillomavirus (HPV) infection are recommended for all adolescents by the World Health Organization (WHO) and are primarily delivered in school-based settings. This systematic review aims to summarize the available evidence on the cost of HPV vaccine delivery in low- and middle-income countries (LMICs). This updated evidence is eminent given recent global efforts to revitalize HPV vaccine delivery following the COVID-19 pandemic and can be used to inform planning for program sustainability. We carried out a systematic review of published literature reporting the costs of HPV vaccine delivery in LMICs published between 2005 and 2023. Eligibility criteria were developed using the Population, Intervention, Comparator, Outcome (PICO) framework, and studies tha

SUBMITTER: Slavkovsky R 

PROVIDER: S-EPMC10911079 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature